NCT05213468 is a NA clinical trial of PainDrainerTM in Chronic Pain, sponsored by PainDrainer AB.

Who is sponsoring NCT05213468?

NCT05213468 is sponsored by PainDrainer AB.

What drugs are being tested in NCT05213468?

Interventions in NCT05213468: PainDrainerTM.

What condition does NCT05213468 study?

NCT05213468 studies Chronic Pain.

Is NCT05213468 still recruiting?

NCT05213468 is currently terminated. Last updated 15 June 2023.

Last reviewed 2023-06-15 · How we verify

NCT05213468

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Self-management of Chronic Pain Though E-health

Terminated NA Last updated 15 June 2023

What this trial tests

NA trial testing PainDrainerTM in Chronic Pain in 6 participants. Terminated before completion.

Timeline

1 February 2022

Primary endpoint
1 April 2023

1 April 2023

Quick facts

Lead sponsor	PainDrainer AB
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	6
Start date	1 February 2022
Primary completion	1 April 2023
Estimated completion	1 April 2023
Sites	1 location across Sweden

Drugs / interventions tested

PainDrainerTM

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

PainDrainer AB

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to validate if a digital tool for increased self-management of chronic pain can improve the quality of life for patients with chronic pain. The validation is based on the change in pain interference (Quality of life), pain intensity, physical functioning, depression, and anxiety based on self-reported information from baseline to study end.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05213468 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PainDrainer AB
Last refreshed: 15 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05213468.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing